Excited to announce that miR Scientific’s #Prostatecancer#Liquidbiopsy urine test has received #BREAKTHROUGH Device Designation from the @US_FDA. Another important milestone on the path to #impact the lives of millions of men worldwide.
https://t.co/DpbPbalGd6
If you are attending the New England Section of the American Urological Association meeting, we would love to see you at the miR Scientific booth, where you can learn more about the miR Sentinel Prostate Cancer Test. #AUA#ProstateCancer#Urology
“During this National Prostate Cancer Awareness Month, let us... join forces as one to protect the health of future generations.” #CanDoBlue#ProstateCancerAwarenessMonth
https://t.co/sU7oFNMaRg
Hello there from #CanDoBlue, this is your friendly reminder that Prostate Cancer Awareness Month is just around the corner! Join the #CanDoBlue campaign to help raise awareness for prostate cancer. Learn how you can join at https://t.co/gQA5KQbijk #VísteteDeAzul#prostatecancer
miR Sentinel Prostate Cancer Test is a simple, one-step urine test that helps answer your two most important questions: Is prostate cancer present? How severe is it? Visit https://t.co/Q6zZrcprYZ to learn more.
#prostatecancer#urology#menshealth
Every year in September, health experts, advocates, & the public join to raise awareness about prostate health & prostate cancer. This year, we are announcing #CanDoBlue! A force of unifying positivity & a rallying cry to support Prostate Cancer Awareness
https://t.co/gQA5KQbijk
The miR Sentinel Prostate Cancer Test provides Prostate Cancer detection and classification, independent of clinical risk factors such as PSA, DRE, or histopathology. Check out https://t.co/Q6zZrc7R7r to learn more.
#prostatecancer#menshealth#urology
The miR Sentinel™ Prostate Cancer Test: Each test provides a comprehensive molecular profile of the entire gland, giving you the confidence to make a more informed decision about the best way to proceed for each patient.
#prostatecancer#menshealth#urology
Accuracy is critical in identifying Prostate Cancer. In a subset analysis of a clinical study of patients who had both fusion and TRUS biopsies, the miR Sentinel™ Prostate Cancer Test identified 99% of cancers that one biopsy missed.
#prostatecancer#menshealth#urology
The miR Sentinel™ Prostate Cancer Test can accurately detect and risk-classify Prostate Cancer, giving patients and providers confidence in the information used to plan management or treatment. Visit https://t.co/Q6zZrc7R7r to learn more!
#prostatecancer#menshealth#urology
miR Scientific is thrilled to introduce miR Sentinel Prostate Cancer Test, an accurate, simple, comprehensive, and non-invasive option to help guide clinical management of men at risk of prostate cancer.
https://t.co/Q6zZrc7R7r #prostatecancer#menshealth#urology
miR Scientific is proud to announce the commercial availability of the breakthrough miR Sentinel™ Prostate Cancer Test! Please check out https://t.co/rQkeOCF9y9 for more information about accessing the test. #prostatecancer#menshealth
https://t.co/s8KNRGNldx
miR Scientific is proud to announce the commercial availability of the breakthrough miR Sentinel™ Prostate Cancer Test! Please check out https://t.co/rQkeOCF9y9 for more information about accessing the test. #prostatecancer#menshealth
https://t.co/zEbR3NOUYk
TODAY: Check out the Precision Medicine World Conference session on Liquid Biopsy for Screening, Diagnosis, Prognosis, and Therapy guidance, chaired by Sam Salman, miR Scientific CEO. #liquidbiopsy#PMWC22
https://t.co/8hJdUrBSfJ
See Why Liquid Biopsy is the Fastest Growing Area in the Medical Diagnostics Field at #PMWC22! Sam Salman, miR Scientific CEO, will chair a session at the Precision Medicine World Conference this week to discuss #liquidbiopsy.
https://t.co/ZAq4ts8p23
NOW AVAILABLE: miR Sentinel™ Prostate Cancer test, a breakthrough non-invasive urine test to accurately detect and risk-classify prostate cancer. Visit our website to learn more about accessing this game-changing new test! https://t.co/Ecmko86q62
NOW AVAILABLE: miR Sentinel™ Prostate Cancer test, a breakthrough non-invasive urine test to accurately detect and risk-classify prostate cancer. Visit our website to learn more about accessing this game-changing new test! https://t.co/Ecmko86q62
Join us for our Podium Presentation at #AUA22! PD11-11: Prostate Cancer: Detection & Screening II. A urinary exosome assay interrogating small non-coding RNAs accurately identifies and stratifies prostate cancer into low-,intermediate-,or high-risk disease.https://t.co/M420ctdl9v
Our breakthrough prostate cancer detection and classification technology, the miR Sentinel™ Prostate Cancer Test, will be accessible to more people with a completely non-invasive, no-contact testing option. Learn more about our science and technology. https://t.co/W1DEsQEYUV